|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Nastech Pharmaceutical Company Inc. (NSTK) Announces Appointment of Gunter Blobel, M.D., Ph.D., to its MDRNA, Inc. Scientific Advisory Board
3/27/2008 8:44:49 AM
BOTHELL, Wash.--(BUSINESS WIRE)--Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) announced today that Günter Blobel, M.D., Ph.D., has joined the Scientific Advisory Board of MDRNA, Inc., Nastech’s wholly-owned subsidiary for the development of RNAi technology and therapeutics. Dr. Blobel is a Howard Hughes Medical Institute investigator at The Rockefeller University in New York City. In 1999, Dr. Blobel was awarded the Nobel Prize in Physiology or Medicine for his work in protein research.
|
|
|
|
|
|
|
|
|
|
|